For the Inventor, By the Inventor

Enter assignee name

Gothenburg, Sweden

Albireo Ab

USPTO Granted Patents = 57

CIPO Patents = 5

EPO Patents = 24

Trademarks = 13

Forward Citations = 661

Loading Chart...

Loading Chart...

43 inventors (with patents filed for the assignee):

Per-Göran Gillberg (51 out of 52 patents)

Ingemar Starke (32 out of 56 patents)

Santosh Shripad Kulkarni (20 out of 52 patents)

4. Nils Ove Gustafsson (16 out of 19 patents)

5. Jessica Elversson (15 out of 15 patents)

6. Hans Graffner (11 out of 11 patents)

7. Nils-Olof Lindberg (10 out of 11 patents)

8. Jan Mattsson (8 out of 11 patents)

9. Anna-Maria Tivert (6 out of 6 patents)

10. Robert Lundqvist (5 out of 5 patents)

11. Ingvar Ymen (5 out of 9 patents)

12. Eva Byröd (5 out of 5 patents)

13. Rikard Bryland (5 out of 5 patents)

14. Ann-Charlotte Dahlquist (5 out of 5 patents)

15. Martin Hans Bohlin (5 out of 28 patents)

Core Competencies:

IBAT Inhibitors

Benzothiazepine Compounds

Bile Acid Modulators

Odevixibat

Crystal Modifications

Oral Cholestyramine

Pharmaceutical Formulations

Progressive Familial Intrahepatic Cholestasis

Liver Diseases

Cholestyramine Granules

Cholestyramine Pellets

Adsorbing Capacity

57 patents: Sort by Forward Citations

1. 12447156 - Treating progressive familial intrahepatic cholestasis (PFIC) with IBAT inhibitors (2025-10-21),

2. 12365658 - Benzothia(di)azepine compounds and their use as bile acid modulators (2025-07-22),

3. 12202809 - Benzothia(di)azepine compounds and their use as bile acid modulators (2025-01-21),

4. 12187812 - IBAT inhibitors for the treatment of liver diseases (2025-01-07),

5. 12187690 - Benzothiadiazepine compounds and their use as bile acid modulators (2025-01-07),

6. 12134606 - Benzothia(di)azepine compounds and their use as bile acid modulators (2024-11-05),

7. 12091394 - Crystal modifications of odevixibat (2024-09-17),

8. 12060338 - Benzothia(di)azepine compounds and their use as bile acid modulators (2024-08-13),

9. 12024495 - Benzothiazepine compounds and their use as bile acid modulators (2024-07-02),

10. 11891368 - Benzothia(di)azepine compounds and their use as bile acid modulators (2024-02-06),

11. 11802115 - Pharmaceutical formulation of odevixibat (2023-10-31),

12. 11801226 - Pharmaceutical formulation of odevixibat (2023-10-31),

13. 11773071 - Benzothiazepine compounds and their use as bile acid modulators (2023-10-03),

14. 11732006 - IBAT inhibitors for the treatment of liver diseases (2023-08-22),

15. 11708340 - Benzothia(di)azepine compounds and their use as bile acid modulators (2023-07-25),

Albireo AB is a technology consulting company that specializes in providing software development and IT solutions. With a team of experienced professionals, Albireo offers a wide range of services to clients in various industries. They leverage their expertise in cutting-edge technologies to deliver innovative and efficient solutions. To learn more about Albireo and their services, visit their website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

57 Patents

#14 in Gothenburg

#118 in Sweden

#12,168 in the World

Gothenburg, Sweden

Albireo Ab

Forward Citations = 661

43 inventors:

Per-Göran Gillberg (51 out of 52 patents)

Ingemar Starke (32 out of 56 patents)

Santosh Shripad Kulkarni (20 out of 52 patents)

4. Nils Ove Gustafsson (16 out of 19 patents)

5. Jessica Elversson (15 out of 15 patents)

Please report any incorrect information to support@idiyas.com

Loading…